no statement of use filed
on 05 Feb 2024
Last Applicant/ Owned by
Economic and Technological Dev. Zone,
Hangzhou, Zhejiang,
CN
310018
Serial Number
90086251 filed on 31st Jul 2020
Registration Number
N/A
Correspondent Address
MONICA RIVA TALLEY
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Chemical analysis; Chemical research; Biological research; Cosmetic research; Chemical engineering Demonstration of goods; Import-export agency services; Organizing exhibitions for technology for business purposes The color(s) blue and green is/are claimed as a feature of the mark. S SOLI PHARMA The mark consists of a circular-shaped design of a globe featuring a highly stylized letter "S", wiRead More
Chemical analysis; Chemical research; Biological research; Cosmetic research; Chemical engineering
Demonstration of goods; Import-export agency services; Organizing exhibitions for technology for business purposes
No 90086251
No Service Mark
No 3663.0290000
No
No
No
No
No
No
No
No
01.07.25 -
Other globes
27.01.04 -
Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps
The mark consists of a circular-shaped design of a globe featuring a highly stylized letter "S", with the top portion of the S in green and the bottom portion in blue, from a macro perspective on the left and the word "SOLIPHARMA" in blue stylized lettering on the right.
| Status Date | Action Taken |
|---|---|
| 05th Feb 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 05th Feb 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 04th Jul 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 09th May 2023 | PUBLISHED FOR OPPOSITION |
| 09th May 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Apr 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Apr 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 02th Apr 2023 | EXPARTE APPEAL TERMINATED |
| 31st Mar 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Mar 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
